oligonucleotide

(redirected from Oligonucleotides)
Also found in: Dictionary, Encyclopedia.

oligonucleotide

 [ol″ĭ-go-noo´kle-o-tīd]
a polymer made up of a few (2 to 10) nucleotides.

ol·i·go·nu·cle·o·tide

(ol'i-gō-nū'klē-ō-tīd),
A compound made up of the condensation of a small number (typically fewer than 20) of nucleotides. Compare: polynucleotide.

oligonucleotide

(ŏl′ĭ-gō-no͞o′klē-ə-tīd, -nyo͞o′-, ō′lĭ-)
n.
A short polymer of two to twenty nucleotides.

ol·i·go·nu·cle·o·tide

(ol'i-gō-nū'klē-ō-tīd)
A compound made up of the condensation of a small number (typically fewer than 20) of nucleotides.
Compare: polynucleotide

oligonucleotide

a short sequence of NUCLEOTIDES. Compare POLYNUCLEOTIDE.

ol·i·go·nu·cle·o·tide

(ol'i-gō-nū'klē-ō-tīd)
A compound made up of the condensation of a small number of nucleotides.
References in periodicals archive ?
The announcement is especially interesting to researchers in the Synthetic Biology and Diagnostic sectors, which require large volumes of both genes and oligonucleotides.
9.5.2.1 Increasing Awareness About Advancements in Oligonucleotides to Drive the Market
"Additionally, the opening of the new oligonucleotide API development center furthers our commitment to enhancing our service offerings and responsiveness to our customers' needs."
Focused presentations on oligonucleotide therapies, opportunities and challenges in drug developments, and securing oligonucleotide supply include:
Wave is developing oligonucleotide therapeutics to target diseases that have been historically difficult to treat with small molecules or biologics.
(21) For example, random oligonucleotides are often synthesized with "wings" attached at either end, consisting of a known sequence.
Unlike existing antisense therapies that target RNA, an antigene drug is a triplex-forming oligonucleotide that recognizes and attaches directly to a specific DNA sequence.
While traditional methods require eight steps and can take two hours, the Clarity OTX extraction kits isolate oligonucleotide therapeutics and their metabolites in 15 minutes.
Editors Moretti and Rizzo (no affiliations listed) have collected research in the field on the use of oligonucleotides for detecting complementary DNA and RNA such as in DNA microarrays and the synthesis of artificial genes.
All regions with a minimum of 5 consecutive oligonucleotides indicating significant copy number variation were investigated further; common copy number variants were assessed by position comparison with copy number variation databases and by comparison with parental CGH patterns, when available.
Methods: Nuclear extracts from hematopoietic and non-hematopoietic cells are incubated with labeled double stranded oligonucleotides from 50-200 bp in length in EMSA binding buffer.
Based in the Netherlands, the business provides oligonucleotides. Financial details were not disclosed.